Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis.
Scheibe F, Ostendorf L, Reincke SM, Prüss H, von Brünneck AC, Köhnlein M, Alexander T, Meisel C, Meisel A. Scheibe F, et al. Among authors: ostendorf l. J Neurol. 2020 Feb;267(2):317-323. doi: 10.1007/s00415-019-09585-6. Epub 2019 Oct 19. J Neurol. 2020. PMID: 31630242
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.
Ostendorf L, Burns M, Durek P, Heinz GA, Heinrich F, Garantziotis P, Enghard P, Richter U, Biesen R, Schneider U, Knebel F, Burmester G, Radbruch A, Mei HE, Mashreghi MF, Hiepe F, Alexander T. Ostendorf L, et al. N Engl J Med. 2020 Sep 17;383(12):1149-1155. doi: 10.1056/NEJMoa2023325. N Engl J Med. 2020. PMID: 32937047
Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus.
Zorn-Pauly L, von Stuckrad ASL, Klotsche J, Rose T, Kallinich T, Enghard P, Ostendorf L, Burns M, Doerner T, Meisel C, Schneider U, Unterwalder N, Burmester G, Hiepe F, Alexander T, Biesen R. Zorn-Pauly L, et al. Among authors: ostendorf l. Rheumatology (Oxford). 2022 Aug 3;61(8):3396-3400. doi: 10.1093/rheumatology/keab875. Rheumatology (Oxford). 2022. PMID: 34849605
Daratumumab for treatment-refractory antibody-mediated diseases in neurology.
Scheibe F, Ostendorf L, Prüss H, Radbruch H, Aschman T, Hoffmann S, Blau IW, Meisel C, Alexander T, Meisel A. Scheibe F, et al. Among authors: ostendorf l. Eur J Neurol. 2022 Jun;29(6):1847-1854. doi: 10.1111/ene.15266. Epub 2022 Feb 10. Eur J Neurol. 2022. PMID: 35098616
Discriminating promiscuous from target-specific autoantibodies in COVID-19.
Lebedin M, García CV, Spatt L, Ratswohl C, Thibeault C, Ostendorf L, Alexander T, Paul F, Sander LE, Kurth F, de la Rosa K. Lebedin M, et al. Among authors: ostendorf l. Eur J Immunol. 2023 May;53(5):e2250210. doi: 10.1002/eji.202250210. Epub 2023 Apr 3. Eur J Immunol. 2023. PMID: 36856018 Free article.
23 results